Completed PHASE4 INTERVENTIONAL 1-arm NCT01180283

Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes.

Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patient With Type II Diabetes. Multicentric Study.

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.

Conditions Erectile Dysfunction

Interventions lodenafil carbonate

Updated 5 times since 2017 Last updated: Aug 10, 2010 Started: Jan 31, 2009 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01180283, this PHASE4 trial focuses on Erectile Dysfunction and remains completed. Sponsored by Cristália Produtos Químicos Farmacêuticos Ltda., it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cristália Produtos Químicos Farmacêuticos Ltda.

Data source: Cristália Produtos Químicos Farmacêuticos Ltda.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santo André, Brazil
• São Paulo, Brazil